Analyst Ratings for Genomic Health Inc. (GHDX)Updated: 2017-07-28
Genomic Health Inc. (NASDAQ:GHDX) was awarded an average rating of Hold from investment analysts following the stock. A consensus rating of Hold was previously issued for GHDX last month.
3 analysts declared GHDX a buy, 0 issued an overweight rating, 8 issued a hold rating, 1 gave an underweight rating, and 1 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. During this time, the number of analysts bearish on the stock has increased by 0.
Investment analysts gave a few price targets for GHDX. The maximum price target given was 40, implying potential capital gains of 23.65 percent. The minimum price target given was 27, implying a possible loss of -16.54 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -200 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -25 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.
In the trailing 52-weeks, GHDX hit 33.97 at the highest peak, while it's lowest trading point was 25.66. Today's price is 26.07 percent above the 52-week low, and below the high by 4.77 percent. GHDX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The GHDX value stock report compares GHDX to some of its peers using value stock charts. The stock has a market capitalization of $1.1 billion. GHDX is estimated to release their earnings results for the quarter on 0000-00-00, days from today.